Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification
Classification of genetic risk for same individual varied considerably depending on chosen GRS.
»
06/10/19
Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
Only presence of metastasis independent prognostic factor.
»
06/10/19
On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer
Single gene on-treatment biomarker had greater predictive accuracy than established prognostic tests.
»
06/14/19
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
Survival analyses suggest that prognostic value of MMPs limited to clear cell renal carcinoma.
»
06/14/19
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
Expressions of VEGF receptors and their ligands significantly differed between malignant ovarian tumors and paired distant metastases.
»
06/14/19
Evaluating diagnostic strategies for early detection of cancer: the CanTest framework
Framework suitable for testing in low prevalence populations.
»
06/14/19
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation
Proscillaridin A demonstrated anticancer activity against lymphoid and myeloid stem cell populations.
»
06/13/19
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors
Somatostatin analogs may in part exert their beneficial effects through alteration in micro-RNA expression profile.
»
06/13/19
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
Eribulin demonstrated to be comparable with other chemotherapy agents with acceptable safety profile.
»
06/13/19
miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives
520d-5p reduced mutation levels in both the whole genome and genomic fragment assemblies.
»
06/15/19
< Prev
Next >